Medical Information
United States
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

BICILLIN® C-R 900/300 Principal Display Panel (penicillin G benzathine, penicillin G procaine - BICILLIN® C-R 900/300)

PRINCIPAL DISPLAY PANEL - 2 mL Syringe Label

NDC 60793-602-02

BICILLIN® C-R 900/300
(900,000 units penicillin G benzathine and
300,000 units penicillin G procaine injectable
suspension)

1,200,000 units per 2 mL

Not for the Treatment of Syphilis
FOR DEEP INTRAMUSCULAR INJECTION ONLY
WARNING: FATAL IF GIVEN BY OTHER ROUTES

Distributed by
Pfizer Inc
New York, NY 10017

PAA105320

Lot:
EXP:(YYMMDD)

PRINCIPAL DISPLAY PANEL - 2 mL Syringe Label

PRINCIPAL DISPLAY PANEL - 2 mL Syringe Package

Ten Syringes (2 mL size)

NDC 60793-602-10
Contains 10 of NDC 60793-602-02

Bicillin® C-R 900/300
(penicillin G benzathine and penicillin G procaine
injectable suspension)

1,200,000 units per 2 mL

FOR PEDIATRIC USE
FOR DEEP INTRAMUSCULAR INJECTION ONLY
WARNING: FATAL IF GIVEN BY OTHER ROUTES
BEFORE INJECTING, SEE PACKAGE INSERT FOR ADMINISTRATION INSTRUCTIONS.
NOT FOR THE TREATMENT OF SYPHILIS

Pfizer Injectables

Rx only

PRINCIPAL DISPLAY PANEL - 2 mL Syringe Package
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event